Clinical pharmacists and inpatient medical care: a systematic review1)

Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical Pharmacists and Inpatient Medical Care. A systematic review. Arch Intern Med 2006;166:955-964 Academic Health Centers. Leading Change in the21st Century. Washington, DC: National Academy Press; 2003. Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human. Washington, DC: National Academy Press;2000. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [published correction appears in JAMA. 2000;283:1293]. JAMA.1999;282:267-270. Smythe MA, Shah PP, Spiteri TL, Lucarotti RL,Begle RL. Pharmaceutical care in medical progressive care patients. Ann Pharmacother. 1998;32:294-299. Bjornson DC, Hiner WO Jr, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875-1884. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health System Pharm. 2002;59: 2089-2092. Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L. Economic consequences of two druguse control systems in a teaching hospital. Am J Hosp Pharm. 1988;45:2329-2340. Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm. 1991;48:1457- 1462. Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997; 54:1591-1595. Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163: 2014-2018. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study: the optimal use of medications in acutely ill older patients. JAmGeriatr Soc. 1990;38:1082-1087. Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58:1309-1316. Nester TM, Hale LS. Effectiveness of a pharmacist acquired medication history in promoting patient safety. Am J Health Syst Pharm. 2002; 59:2221-2225. Stowasser DA, Collins DM, Stowasser M. A randomized controlled trial of medication liaison services, I: patient outcomes. J Pharm Pract Res. 2002;32:133-140. Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital.Br J Clin Pharmacol. 1997;44:163-165. Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci. 2004;26:114-120. Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995;160:561-564. Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing: a randomized controlled trial. Med Care. 1992;30:646-658. Johnston M, Clarke A, Mundy K, Cromarty E, Ridout K. Facilitating comprehension of discharge medication in elderly patients. Age Ageing. 1986; 15:304-306. Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing. 2001;30:33-40. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54:657- 664. Schnipper JL, Kirwin JL, Cotugno MC, et al.Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-571. Mamdani MM, Racine E, McCreadie S, et al. Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy. 1999;19:1064-1074. Dager WE, Branch JM, King JH, et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother. 2000; 34:567-572. Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm. 1992;49:387-394. Tschol N, Lai DK, Tilley JA, Wong H, Brown GR. Comparison of physician- and pharmacistmanaged warfarin sodium treatment in open heart surgery patients. Can J Cardiol. 2003;19:1413- 1417. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157: 1689-1694. Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000;57:268-274. Bailey TC, Ritchie DJ, McMullin ST, et al. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy. 1997;17:277-281. Gums JG, YanceyRWJr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999;19:1369-1377. Destache CJ, Meyer SK, Bittner MJ, Hermann KG. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a costbenefit analysis. Ther Drug Monit. 1990;12: 419-426. Destache CJ, Meyer SK, Padomek MT, Ortmeier BG. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gramnegative infections. DICP. 1989;23:33-38. Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on patient care. Ann Pharmacother. 1994;28:1335-1339. Burton ME, Ash CL, Hill DP, Handy T, Shepherd MD, Vasko MR. A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration. Clin Pharmacol Ther. 1991;49: 685-694. Winter ME, Herfindal ET, Bernstein LR. Impact of decentralized pharmacokinetics consultation service. Am J Hosp Pharm. 1986;43:2178-2184. Leehey DJ, Braun BI, Tholl DA, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol. 1993;4:81-90. Wing DS, Duff HJ. The impact of a therapeutic drug monitoring program for phenytoin. Ther Drug